Recruitment Strategies, Response Rates, and Non-Response Patterns in a Nationwide Registry-Based PRO Survey of Cancer Survivors and the General Population: The SURV-ICE Cohort
Authors:
- Kristjana SigurðardóttirKSKristjana Sigurðardóttir
- Nanna FriðriksdóttirNFNanna Friðriksdóttir
- Nanna Margrét KristinsdóttirNKNanna Margrét Kristinsdóttir
- Lára KristjánsdóttirLKLára Kristjánsdóttir
- Hjalti Gunnlaugur SkúlasonHSHjalti Gunnlaugur Skúlason
- Álfheiður HaraldsdóttirÁHÁlfheiður Haraldsdóttir
- Sigríður Ása AlfonsdóttirSASigríður Ása Alfonsdóttir
- Anna Kristín B. JóhannesdóttirAJAnna Kristín B. Jóhannesdóttir
- Helgi BirgissonHBHelgi Birgisson
- Helga TryggvadóttirHTHelga Tryggvadóttir
- Freyja BirgisdóttirFBFreyja Birgisdóttir
- Heiðdís ValdimarsdóttirHVHeiðdís Valdimarsdóttir
Open Access
Abstract
Background: Population-based studies using patient-reported outcomes provide important insights into health-related quality of life (HRQoL) and the long-term impact of cancer and its treatment. Declining response rates and potential non-response bias have presented methodological challenges, particularly in registry-based surveys including both cancer survivors and population controls. The SURV-ICE study was established to assess HRQoL and health literacy among cancer survivors in Iceland while evaluating recruitment processes and participation patterns in a nationwide mixed-mode survey. Methods: SURV-ICE is a nationwide, population-based cross-sectional survey conducted in Iceland in 2025. Adults diagnosed with invasive cancer between 2014 and 2024 were identified through the Icelandic Cancer Registry and invited alongside an age- and gender-matched control group sampled from national registers. Participants completed validated EORTC instruments. Recruitment used a mixed-mode strategy including postal invitations, web-based and paper questionnaires, electronic reminders via the national health portal, and targeted telephone follow-up. Results: Among 10,005 cancer survivors 5489 (54.9%) responded to the questionnaires and among 5663 controls 2297 (40.6%) responded to the questionnaires. In both groups participation peaked among individuals aged 60–79 years and was lowest among the youngest and oldest groups. Cancer survivors had higher odds of participation than controls (OR 1.84; 95% CI 1.72–1.97). Most responses followed the initial postal invitation and first electronic reminder. Data completeness was high (≥80% item completion in 95.7% of instruments). Conclusions: Nationwide registry-based recruitment for large-scale PRO research is feasible in Iceland and can achieve competitive response rates without incentives. SURV-ICE provides an infrastructure for future research on cancer survivorship, HRQoL, and health literacy.Keywords
Funding Information
- Landspitali (C-2025-04)
- Icelandic Nurses’ Association Science Fund
This publication has 54 references indexed in Scilit:
- A nationwide, longitudinal collection of patient-reported outcomes from prostate cancer patients and controlsQuality of Life Research, 2025
- Interventions influencing patient-reported outcomes (PROs) response rates in cancer: a scoping reviewJournal of Cancer Survivorship, 2025
- Survey response rates in European comparative surveys: a 20-year decline irrespective of sampling frames or survey modesQuality & Quantity, 2024
- Patient-Reported Outcome Measures in Cancer CareJAMA Network Open, 2024
- The Importance of Patient Reported Outcomes in Oncology Clinical Trials and Clinical Practice to Inform Regulatory and Healthcare Decision-MakingDrugs in R&D, 2024
- Patient-reported outcome measures after treatment for prostate cancer: Results from the Danish Prostate Cancer Registry (DAPROCAdata)Cancer Epidemiology, 2020
- Cancer survivorship: an integral part of Europe's research agendaMolecular Oncology, 2018
- Non-response in surveys of very old peopleEuropean Journal of Ageing, 2018
- Internet, Phone, Mail, and Mixed‐Mode Surveys2014
- Participation Rates in Epidemiologic StudiesAnnals of Epidemiology, 2007